Our Services
Medical Information
Helpful Resources
Published on: 1/28/2026
Treatment for bowel inflammation from IBD is individualized and centers on medications that reduce inflammation and maintain remission, including aminosalicylates, short-term steroids for flares, immunomodulators, biologic therapies, and small-molecule drugs, supported by nutrition and lifestyle measures. Surgery may be needed for complications or severe disease and can be curative in ulcerative colitis but not in Crohn’s, with long-term monitoring to prevent flares and complications; there are several factors to consider, so see the complete details below.
Inflammation of the bowel is most often caused by Inflammatory Bowel Disease (IBD). IBD is a long-term condition that mainly includes Crohn's disease and ulcerative colitis. These conditions cause ongoing inflammation in the digestive tract and can lead to symptoms such as diarrhea, abdominal pain, fatigue, weight loss, and rectal bleeding.
While IBD is a serious medical condition, effective treatments are available. Many people with IBD live full, active lives with the right care plan. Treatment is usually long-term and tailored to the individual, based on how severe the disease is, which part of the bowel is affected, and how the body responds to therapy.
Below is a clear, medically accurate overview of how inflammation of the bowel (IBD) is treated, using guidance aligned with major gastroenterology organizations.
The main goals of IBD treatment are to:
There is currently no cure for IBD, but treatment can place the disease into remission, sometimes for long periods.
Medication is the primary treatment for most people with IBD. Different drugs work in different ways, and many patients use more than one over time.
These drugs help calm inflammation in the bowel and are often used for mild to moderate IBD.
Aminosalicylates (5-ASAs)
Corticosteroids (steroids)
IBD involves an overactive immune response. These medications reduce immune system activity to limit inflammation.
Immunomodulators
Biologic therapies
Small-molecule medications
Medication choice depends on disease type, severity, prior response, and safety considerations. Regular follow-up is important to monitor effectiveness and side effects.
Food does not cause IBD, but diet can strongly affect symptoms and healing.
Some people with IBD may need:
There is no single "IBD diet", and extreme food restriction is not recommended without medical guidance. A registered dietitian experienced in IBD can be very helpful.
Lifestyle changes do not replace medical therapy, but they can support overall health and symptom control.
Helpful steps include:
Mental health support is also important. Anxiety or depression is common in chronic illness and deserves attention.
Surgery is sometimes required when medications are not effective or when complications develop.
Surgery is typically planned carefully and not considered a failure of treatment.
IBD requires ongoing monitoring, even during remission.
This may include:
Regular monitoring helps:
IBD is not the same as Irritable Bowel Syndrome (IBS).
Symptoms can overlap, which sometimes leads to confusion. If you're experiencing digestive symptoms but aren't sure whether they point to IBS or something else, you can use a free Irritable Bowel Syndrome (IBS) symptom checker to help clarify your symptoms and guide your next steps with a healthcare professional.
You should speak to a doctor promptly if you have:
Seek urgent medical care if symptoms are severe, worsening quickly, or feel life-threatening.
IBD is a complex medical condition that requires professional diagnosis and treatment. Early care can reduce complications and improve long-term outcomes.
If you think you may have IBD—or if your symptoms are changing or worsening—speak to a doctor. With the right treatment plan, most people with IBD can manage their condition and maintain a good quality of life.
(References)
* Ng SC, Shi HY, Hamidi H, et al. Novel Therapeutic Strategies for Inflammatory Bowel Disease. Int J Mol Sci. 2022 Nov 3;23(21):13488. doi: 10.3390/ijms232113488. PMID: 36362141.
* Chang JT. Treatment of Inflammatory Bowel Disease: A Review. Gastroenterol Clin North Am. 2023 Jun;52(2):299-317. doi: 10.1016/j.gtc.2023.01.004. PMID: 37119934.
* Peyrin-Biroulet L, et al. Advances in the Management of Inflammatory Bowel Disease: A Review. JAMA. 2022 Nov 15;328(19):1947-1959. doi: 10.1001/jama.2022.20370. PMID: 36378278.
* Singh S, et al. Current and Emerging Therapeutic Options for Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1199-1212.e1. doi: 10.1016/j.cgh.2021.08.016. PMID: 34419515.
* Ma C, et al. Treatment algorithms for inflammatory bowel disease. Gastroenterol Clin North Am. 2020 Dec;49(4):755-783. doi: 10.1016/j.gtc.2020.08.005. PMID: 33153606.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.